View in EDS HTML Full Text PDF Full Text

Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis.

Saved in:
Bibliographic Details
Title: Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis.
Authors: Peng, Tzu-Rong1 (AUTHOR) tzu.rong@tzuchi.com.tw, Weng, Yi-Fang1 (AUTHOR) u108534011@gap.kmu.edu.tw, Wu, Ta-Wei1 (AUTHOR) tawei@tzuchi.com.tw, Wu, Chao-Chuan2,3 (AUTHOR) ngchiukwan@yahoo.com.tw, Chou, Yi-Chun3,4 (AUTHOR), Hsu, Ching-Sheng4,5,6 (AUTHOR) hsu.chingsheng@gmail.com
Source: Cancers. Aug2024, Vol. 16 Issue 16, p2813. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179353780
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Peng%2C+Tzu-Rong%22">Peng, Tzu-Rong</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> tzu.rong@tzuchi.com.tw</i><br /><searchLink fieldCode="AR" term="%22Weng%2C+Yi-Fang%22">Weng, Yi-Fang</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> u108534011@gap.kmu.edu.tw</i><br /><searchLink fieldCode="AR" term="%22Wu%2C+Ta-Wei%22">Wu, Ta-Wei</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> tawei@tzuchi.com.tw</i><br /><searchLink fieldCode="AR" term="%22Wu%2C+Chao-Chuan%22">Wu, Chao-Chuan</searchLink><relatesTo>2,3</relatesTo> (AUTHOR)<i> ngchiukwan@yahoo.com.tw</i><br /><searchLink fieldCode="AR" term="%22Chou%2C+Yi-Chun%22">Chou, Yi-Chun</searchLink><relatesTo>3,4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hsu%2C+Ching-Sheng%22">Hsu, Ching-Sheng</searchLink><relatesTo>4,5,6</relatesTo> (AUTHOR)<i> hsu.chingsheng@gmail.com</i>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Cancers%22">Cancers</searchLink>. Aug2024, Vol. 16 Issue 16, p2813. 11p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179353780
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/cancers16162813
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 11
        StartPage: 2813
    Titles:
      – TitleFull: Efficacy and Safety of Sorafenib or Lenvatinib for Advanced Hepatocellular Carcinoma after Failure of First-Line Atezolizumab Plus Bevacizumab: A Systematic Review and Meta-Analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Peng, Tzu-Rong
      – PersonEntity:
          Name:
            NameFull: Weng, Yi-Fang
      – PersonEntity:
          Name:
            NameFull: Wu, Ta-Wei
      – PersonEntity:
          Name:
            NameFull: Wu, Chao-Chuan
      – PersonEntity:
          Name:
            NameFull: Chou, Yi-Chun
      – PersonEntity:
          Name:
            NameFull: Hsu, Ching-Sheng
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 08
              Text: Aug2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20726694
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 16
          Titles:
            – TitleFull: Cancers
              Type: main
ResultId 1